MSK Pharmalogistic Gmbh Pharmaceutical Import Profile — Germany (DGFT 2022–2026)

Name: MSK Pharmalogistic Gmbh Pharmaceutical Import Records from India — 2 Products, $2.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

MSK Pharmalogistic Gmbh — Pharmaceutical Importer Profile (2026) | 2 Products, $2.9M Trade | TransData Nexus

MSK Pharmalogistic Gmbh

Pharmaceutical Importer · Germany · Ayurvedic & Herbal Products Focus · $2.9M Total Trade · DGFT Verified

MSK Pharmalogistic Gmbh is a pharmaceutical importer based in Germany with a total trade value of $2.9M across 2 products in 2 therapeutic categories. Based on 58 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. MSK Pharmalogistic Gmbh sources from 1 verified Indian supplier, with Micro Labs Limited accounting for 100.0% of imports.

MSK Pharmalogistic Gmbh — Import Portfolio & Supplier Network

MSK Pharmalogistic Gmbh import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to MSK Pharmalogistic Gmbh?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Micro Labs Limited	$20.2M	1,124	100.0%

MSK Pharmalogistic Gmbh sources from 1 verified Indian supplier across 767 distinct formulations. The sourcing is highly concentrated — Micro Labs Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does MSK Pharmalogistic Gmbh Import?

Formulation	Value	Ships
Amoxicillin/clavulansaure micro labs	$1.1M	24
Amoxicillin micro labs 1000 MG	$297.9K	6
Diclofenac natrium micro labs 75MG	$292.1K	11
Dorzolamide preservative-free 20MG/ML	$200.0K	4
Etoricoxib micro labs 60MG	$176.3K	6
Solifenacin micro labs 5 MG	$161.0K	9
Amoxicillin/clavulansaure micro labs 875/125MG filmtabletten co-amoxiclan+875MG/125MG BP Film-Coated tablets 2x10s	$150.0K	3
Dorzolamide preservative free 20MG/ML eye drops ( solution single dose container) ( 120x0.2ML ) ( qty - 2493.000 )	$150.0K	3
Ezetimib micro labs 10MG tabletten ( (ezetimibe 10MG tablets) ) ( 10x10s ) ( qty- 77656.000	$147.2K	3
Pharma : pantoprazole micro labs 40MG	$141.3K	3
Ezetimibe micro labs 10 MG tabletten ( (ezetimibe tablets 10MG) ) ( 10x10s ) ( qty- 57800.000	$126.6K	3
Ezetimibe micro labs 10 MG tabletten ( (ezetimibe tablets 10MG) ) ( 10x10s ) ( qty- 58156.000	$125.9K	3
Amoxicillin/clavulansaure micro labs 875/125 filmtabletten (co-amoxiclav 875MG/125MG film coated BP tablets) (2x10s	$124.1K	6
Pantoprazol-micro labs 40MG	$118.3K	3
Etoricoxib micro labs 90 MG filmtabletten (etoricoxib tablets 90MG) (10x10 s	$118.2K	3

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Vati	Ayurvedic & Herbal Products	$1.6M	32	4.0%	3
2	Ezetimibe	Lipid & Metabolism	$1.3M	26	0.3%	15

MSK Pharmalogistic Gmbh imports 2 pharmaceutical products across 2 categories into Germany totaling $2.9M.

MSK Pharmalogistic Gmbh — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

MSK Pharmalogistic GmbH is a family-owned pharmaceutical logistics company headquartered in Heppenheim, Germany. Established in 1998, the company has over two decades of experience in the healthcare sector, specializing in the storage, packaging, and distribution of pharmaceutical products. Their services encompass logistics, contract packaging, marketing, and sales support, positioning them as a comprehensive service provider for the pharmaceutical industry. (companyhouse.de)

The company's management team includes Simon Heß, Klaus-Dieter Heß, and Marion Heß, with Harald Rohatsch and Thomas Forster serving as authorized signatories. MSK Pharmalogistic GmbH operates under the legal framework of a Gesellschaft mit beschränkter Haftung (GmbH), a common corporate structure in Germany. (companyhouse.de)

2Distribution Network

MSK Pharmalogistic GmbH's distribution network is centered in Heppenheim, Hessen, Germany. The company operates a 4,500-square-meter temperature-controlled storage facility, ensuring the safe and compliant storage of pharmaceutical products. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's infrastructure supports the storage and distribution of prescription, pharmacy-only, and over-the-counter products across Europe. (wlw.de)

3Industry Role

MSK Pharmalogistic GmbH functions primarily as a pharmaceutical logistics service provider, offering storage, packaging, and distribution services to pharmaceutical companies. Their role encompasses aspects of wholesale distribution, contract packaging, and logistics management, serving as an intermediary between pharmaceutical manufacturers and end-users. The company's services are integral to the pharmaceutical supply chain, ensuring the efficient and compliant delivery of pharmaceutical products. (wlw.de)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — MSK Pharmalogistic Gmbh

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

MSK Pharmalogistic GmbH's sourcing strategy exhibits a high degree of concentration, with a total import value of $2.9 million USD from India across 58 shipments, all sourced from a single supplier, MICRO LABS LIMITED. This single-source dependency indicates a strategic choice to maintain a focused and potentially more manageable supplier relationship. The consistent volume of shipments suggests a stable and ongoing partnership, reducing the complexities associated with managing multiple suppliers. However, this concentration also exposes the company to risks related to supply chain disruptions, such as production delays or regulatory changes affecting the sole supplier.

2Supply Chain Resilience

The resilience of MSK Pharmalogistic GmbH's supply chain is closely tied to its exclusive relationship with MICRO LABS LIMITED. The absence of backup suppliers and the focus on a single supplier may limit the company's ability to quickly adapt to supply chain disruptions. The diversity of formulations imported, totaling 767 unique formulations, indicates a broad product range, which could mitigate some risks by offering alternative products within the same therapeutic categories. However, the reliance on a single supplier for all imports from India suggests that any disruptions affecting MICRO LABS LIMITED could significantly impact MSK Pharmalogistic GmbH's operations.

Importing Pharmaceuticals into Germany — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Germany

1Regulatory Authority & Framework

In Germany, the primary regulatory authority overseeing pharmaceutical imports is the Federal Institute for Drugs and Medical Devices (BfArM). The key legislation governing pharmaceutical imports includes the Medicines Act (AMG), which outlines the requirements for the import, distribution, and marketing of medicinal products. The marketing authorization pathway for Indian generics involves obtaining approval from the European Medicines Agency (EMA) or through national procedures, ensuring that imported generics meet the stringent standards set by European regulators.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in Germany are stringent, necessitating compliance with Good Manufacturing Practice (GMP) standards. Certificates such as EU GMP, WHO GMP, and PIC/S are recognized, and products must be accompanied by appropriate documentation to demonstrate compliance. Wholesale distribution authorization is also required, ensuring that entities involved in the distribution of pharmaceutical products adhere to the regulatory standards set forth by German authorities.

3Quality & Labeling

MSK Pharmalogistic Gmbh — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

MSK Pharmalogistic GmbH's focus on Ayurvedic & Herbal Products and Lipid & Metabolism therapeutic categories aligns with current market trends emphasizing natural and holistic health solutions. The demand for Ayurvedic and herbal products is growing, driven by consumer interest in alternative medicine and natural remedies. Similarly, products targeting lipid and metabolism disorders remain in demand due to the prevalence of lifestyle-related health issues. This strategic focus allows MSK Pharmalogistic GmbH to cater to specific market needs and differentiate itself in the competitive pharmaceutical logistics sector.

2Sourcing Profile

MSK Pharmalogistic GmbH's sourcing strategy is centered on importing finished pharmaceutical formulations from India, particularly in the Ayurvedic & Herbal Products and Lipid & Metabolism categories. This approach leverages India's established pharmaceutical manufacturing capabilities and cost advantages. The company's exclusive relationship with MICRO LABS LIMITED suggests a preference for suppliers that can offer a diverse range of formulations and meet stringent quality standards. This sourcing profile enables MSK Pharmalogistic GmbH to provide a comprehensive product portfolio to its clients.

3Market Positioning

Seller's Guide — How to Become a Supplier to MSK Pharmalogistic Gmbh

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with MSK Pharmalogistic GmbH, especially those offering high-quality finished pharmaceutical formulations in the Ayurvedic & Herbal Products and Lipid & Metabolism categories. The company's existing sourcing concentration indicates a potential openness to diversifying its supplier base, which could enhance supply chain resilience and product variety. However, new suppliers must meet the stringent quality standards and regulatory requirements set by German authorities to establish a successful partnership.

2Requirements & Qualifications

Indian exporters seeking to supply MSK Pharmalogistic GmbH and the German market must obtain the necessary import licenses and ensure compliance with GMP standards recognized by German authorities. Products must be accompanied by appropriate certifications, such as EU GMP, WHO GMP, or PIC/S, and meet labeling requirements in German. Additionally, adherence to serialization mandates and batch testing protocols is essential to ensure product quality and safety.

3How to Approach

Frequently Asked Questions — MSK Pharmalogistic Gmbh

What products does MSK Pharmalogistic Gmbh import from India?

MSK Pharmalogistic Gmbh imports 2 pharmaceutical products across 2 categories. Top imports: Vati ($1.6M), Ezetimibe ($1.3M).

Who supplies pharmaceuticals to MSK Pharmalogistic Gmbh from India?

MSK Pharmalogistic Gmbh sources from 1 verified Indian suppliers. The primary supplier is Micro Labs Limited (100.0% of imports, $20.2M).

What is MSK Pharmalogistic Gmbh's total pharmaceutical import value?

MSK Pharmalogistic Gmbh's total pharmaceutical import value from India is $2.9M, based on 58 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does MSK Pharmalogistic Gmbh focus on?

MSK Pharmalogistic Gmbh imports across 2 categories. The largest: Ayurvedic & Herbal Products (55.2%), Lipid & Metabolism (44.8%).

Get Full MSK Pharmalogistic Gmbh Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.